Investigation	B:C0220825
of	O
the	O
mycobacterial	O
enzyme	O
HsaD	O
as	O
a	O
potential	O
novel	O
target	O
for	O
anti-tubercular	O
agents	I:C0003448
using	O
a	O
fragment	O
-	O
based	O
drug	O
design	O
approach	O

Investigation	O
of	O
the	O
mycobacterial	O
enzyme	B:C0014442
HsaD	O
as	O
a	O
potential	O
novel	O
target	O
for	O
anti-tubercular	O
agents	I:C0003448
using	O
a	O
fragment	O
-	O
based	O
drug	O
design	O
approach	O

Investigation	O
of	O
the	O
mycobacterial	O
enzyme	O
HsaD	B:C2352472
as	O
a	O
potential	O
novel	O
target	O
for	O
anti-tubercular	O
agents	I:C0003448
using	O
a	O
fragment	O
-	O
based	O
drug	O
design	O
approach	O

Investigation	O
of	O
the	O
mycobacterial	O
enzyme	O
HsaD	O
as	O
a	O
potential	O
novel	O
target	O
for	O
anti-tubercular	B:C0003448
agents	I:C0003448
using	O
a	O
fragment	O
-	O
based	O
drug	O
design	O
approach	O

Investigation	O
of	O
the	O
mycobacterial	O
enzyme	O
HsaD	O
as	O
a	O
potential	O
novel	O
target	O
for	O
anti-tubercular	O
agents	I:C0003448
using	O
a	O
fragment	O
-	O
based	O
drug	O
design	O
approach	B:C0449445

With	O
the	O
emergence	O
of	O
extensively	B:C1827301
drug	I:C1827301
-	I:C1827301
resistant	I:C1827301
tuberculosis	I:C1827301
,	O
there	O
is	O
a	O
need	O
for	O
new	O
anti-tubercular	O
drugs	I:C0003448
that	O
work	O
through	O
novel	O
mechanisms	O
of	O
action	O
.	O

With	O
the	O
emergence	O
of	O
extensively	O
drug	I:C1827301
-	I:C1827301
resistant	I:C1827301
tuberculosis	I:C1827301
,	O
there	O
is	O
a	O
need	O
for	O
new	O
anti-tubercular	B:C0003448
drugs	I:C0003448
that	O
work	O
through	O
novel	O
mechanisms	O
of	O
action	O
.	O

The	O
meta	B:C0020289
cleavage	I:C0020289
product	I:C0020289
hydrolase	I:C0020289
,	O
HsaD	O
,	O
has	O
been	O
demonstrated	O
to	O
be	O
critical	O
for	O
the	O
survival	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
in	O
macrophages	O
and	O
is	O
encoded	O
in	O
an	O
operon	O
involved	O
in	O
cholesterol	O
catabolism	I:C1156534
,	O
which	O
is	O
identical	O
in	O
M.	O
tuberculosis	I:C0026926
and	O
M.	O
bovis	I:C0085957
BCG	I:C0085957
.	O

The	O
meta	O
cleavage	I:C0020289
product	I:C0020289
hydrolase	I:C0020289
,	O
HsaD	B:C2352472
,	O
has	O
been	O
demonstrated	O
to	O
be	O
critical	O
for	O
the	O
survival	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
in	O
macrophages	O
and	O
is	O
encoded	O
in	O
an	O
operon	O
involved	O
in	O
cholesterol	O
catabolism	I:C1156534
,	O
which	O
is	O
identical	O
in	O
M.	O
tuberculosis	I:C0026926
and	O
M.	O
bovis	I:C0085957
BCG	I:C0085957
.	O

The	O
meta	O
cleavage	I:C0020289
product	I:C0020289
hydrolase	I:C0020289
,	O
HsaD	O
,	O
has	O
been	O
demonstrated	O
to	O
be	O
critical	O
for	O
the	O
survival	O
of	O
Mycobacterium	B:C0026926
tuberculosis	I:C0026926
in	O
macrophages	O
and	O
is	O
encoded	O
in	O
an	O
operon	O
involved	O
in	O
cholesterol	O
catabolism	I:C1156534
,	O
which	O
is	O
identical	O
in	O
M.	O
tuberculosis	I:C0026926
and	O
M.	O
bovis	I:C0085957
BCG	I:C0085957
.	O

The	O
meta	O
cleavage	I:C0020289
product	I:C0020289
hydrolase	I:C0020289
,	O
HsaD	O
,	O
has	O
been	O
demonstrated	O
to	O
be	O
critical	O
for	O
the	O
survival	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
in	O
macrophages	B:C0024432
and	O
is	O
encoded	O
in	O
an	O
operon	O
involved	O
in	O
cholesterol	O
catabolism	I:C1156534
,	O
which	O
is	O
identical	O
in	O
M.	O
tuberculosis	I:C0026926
and	O
M.	O
bovis	I:C0085957
BCG	I:C0085957
.	O

The	O
meta	O
cleavage	I:C0020289
product	I:C0020289
hydrolase	I:C0020289
,	O
HsaD	O
,	O
has	O
been	O
demonstrated	O
to	O
be	O
critical	O
for	O
the	O
survival	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
in	O
macrophages	O
and	O
is	O
encoded	O
in	O
an	O
operon	B:C0029073
involved	O
in	O
cholesterol	O
catabolism	I:C1156534
,	O
which	O
is	O
identical	O
in	O
M.	O
tuberculosis	I:C0026926
and	O
M.	O
bovis	I:C0085957
BCG	I:C0085957
.	O

The	O
meta	O
cleavage	I:C0020289
product	I:C0020289
hydrolase	I:C0020289
,	O
HsaD	O
,	O
has	O
been	O
demonstrated	O
to	O
be	O
critical	O
for	O
the	O
survival	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
in	O
macrophages	O
and	O
is	O
encoded	O
in	O
an	O
operon	O
involved	O
in	O
cholesterol	B:C1156534
catabolism	I:C1156534
,	O
which	O
is	O
identical	O
in	O
M.	O
tuberculosis	I:C0026926
and	O
M.	O
bovis	I:C0085957
BCG	I:C0085957
.	O

The	O
meta	O
cleavage	I:C0020289
product	I:C0020289
hydrolase	I:C0020289
,	O
HsaD	O
,	O
has	O
been	O
demonstrated	O
to	O
be	O
critical	O
for	O
the	O
survival	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
in	O
macrophages	O
and	O
is	O
encoded	O
in	O
an	O
operon	O
involved	O
in	O
cholesterol	O
catabolism	I:C1156534
,	O
which	O
is	O
identical	O
in	O
M.	B:C0026926
tuberculosis	I:C0026926
and	O
M.	O
bovis	I:C0085957
BCG	I:C0085957
.	O

The	O
meta	O
cleavage	I:C0020289
product	I:C0020289
hydrolase	I:C0020289
,	O
HsaD	O
,	O
has	O
been	O
demonstrated	O
to	O
be	O
critical	O
for	O
the	O
survival	O
of	O
Mycobacterium	O
tuberculosis	I:C0026926
in	O
macrophages	O
and	O
is	O
encoded	O
in	O
an	O
operon	O
involved	O
in	O
cholesterol	O
catabolism	I:C1156534
,	O
which	O
is	O
identical	O
in	O
M.	O
tuberculosis	I:C0026926
and	O
M.	B:C0085957
bovis	I:C0085957
BCG	I:C0085957
.	O

We	O
generated	O
a	O
mutant	B:C0596988
strain	O
of	O
M.	O
bovis	I:C0085957
BCG	I:C0085957
with	O
a	O
deletion	O
of	O
hsaD	O
and	O
tested	O
its	O
growth	O
on	O
cholesterol	O
.	O

We	O
generated	O
a	O
mutant	O
strain	O
of	O
M.	B:C0085957
bovis	I:C0085957
BCG	I:C0085957
with	O
a	O
deletion	O
of	O
hsaD	O
and	O
tested	O
its	O
growth	O
on	O
cholesterol	O
.	O

We	O
generated	O
a	O
mutant	O
strain	O
of	O
M.	O
bovis	I:C0085957
BCG	I:C0085957
with	O
a	O
deletion	B:C1511760
of	O
hsaD	O
and	O
tested	O
its	O
growth	O
on	O
cholesterol	O
.	O

We	O
generated	O
a	O
mutant	O
strain	O
of	O
M.	O
bovis	I:C0085957
BCG	I:C0085957
with	O
a	O
deletion	O
of	O
hsaD	B:C0017337
and	O
tested	O
its	O
growth	O
on	O
cholesterol	O
.	O

We	O
generated	O
a	O
mutant	O
strain	O
of	O
M.	O
bovis	I:C0085957
BCG	I:C0085957
with	O
a	O
deletion	O
of	O
hsaD	O
and	O
tested	O
its	O
growth	O
on	O
cholesterol	B:C0008377
.	O

Using	O
a	O
fragment	O
based	O
approach	B:C0449445
,	O
over	O
1000	O
compounds	O
were	O
screened	O
by	O
a	O
combination	O
of	O
differential	O
scanning	I:C0016352
fluorimetry	I:C0016352
,	O
NMR	O
spectroscopy	I:C0877853
and	O
enzymatic	O
assay	I:C2717977
with	O
pure	O
recombinant	O
HsaD	O
to	O
identify	O
potential	O
inhibitors	O
.	O

Using	O
a	O
fragment	O
based	O
approach	O
,	O
over	O
1000	O
compounds	B:C1706082
were	O
screened	O
by	O
a	O
combination	O
of	O
differential	O
scanning	I:C0016352
fluorimetry	I:C0016352
,	O
NMR	O
spectroscopy	I:C0877853
and	O
enzymatic	O
assay	I:C2717977
with	O
pure	O
recombinant	O
HsaD	O
to	O
identify	O
potential	O
inhibitors	O
.	O

Using	O
a	O
fragment	O
based	O
approach	O
,	O
over	O
1000	O
compounds	O
were	O
screened	B:C0373483
by	O
a	O
combination	O
of	O
differential	O
scanning	I:C0016352
fluorimetry	I:C0016352
,	O
NMR	O
spectroscopy	I:C0877853
and	O
enzymatic	O
assay	I:C2717977
with	O
pure	O
recombinant	O
HsaD	O
to	O
identify	O
potential	O
inhibitors	O
.	O

Using	O
a	O
fragment	O
based	O
approach	O
,	O
over	O
1000	O
compounds	O
were	O
screened	O
by	O
a	O
combination	O
of	O
differential	B:C0016352
scanning	I:C0016352
fluorimetry	I:C0016352
,	O
NMR	O
spectroscopy	I:C0877853
and	O
enzymatic	O
assay	I:C2717977
with	O
pure	O
recombinant	O
HsaD	O
to	O
identify	O
potential	O
inhibitors	O
.	O

Using	O
a	O
fragment	O
based	O
approach	O
,	O
over	O
1000	O
compounds	O
were	O
screened	O
by	O
a	O
combination	O
of	O
differential	O
scanning	I:C0016352
fluorimetry	I:C0016352
,	O
NMR	B:C0877853
spectroscopy	I:C0877853
and	O
enzymatic	O
assay	I:C2717977
with	O
pure	O
recombinant	O
HsaD	O
to	O
identify	O
potential	O
inhibitors	O
.	O

Using	O
a	O
fragment	O
based	O
approach	O
,	O
over	O
1000	O
compounds	O
were	O
screened	O
by	O
a	O
combination	O
of	O
differential	O
scanning	I:C0016352
fluorimetry	I:C0016352
,	O
NMR	O
spectroscopy	I:C0877853
and	O
enzymatic	B:C2717977
assay	I:C2717977
with	O
pure	O
recombinant	O
HsaD	O
to	O
identify	O
potential	O
inhibitors	O
.	O

Using	O
a	O
fragment	O
based	O
approach	O
,	O
over	O
1000	O
compounds	O
were	O
screened	O
by	O
a	O
combination	O
of	O
differential	O
scanning	I:C0016352
fluorimetry	I:C0016352
,	O
NMR	O
spectroscopy	I:C0877853
and	O
enzymatic	O
assay	I:C2717977
with	O
pure	O
recombinant	O
HsaD	B:C2352472
to	O
identify	O
potential	O
inhibitors	O
.	O

Using	O
a	O
fragment	O
based	O
approach	O
,	O
over	O
1000	O
compounds	O
were	O
screened	O
by	O
a	O
combination	O
of	O
differential	O
scanning	I:C0016352
fluorimetry	I:C0016352
,	O
NMR	O
spectroscopy	I:C0877853
and	O
enzymatic	O
assay	I:C2717977
with	O
pure	O
recombinant	O
HsaD	O
to	O
identify	O
potential	O
inhibitors	B:C0243077
.	O

We	O
used	O
enzymological	O
and	O
structural	B:C2603343
studies	I:C2603343
to	O
investigate	O
derivatives	O
of	O
the	O
inhibitors	O
identified	O
and	O
to	O
test	O
their	O
effects	O
on	O
growth	O
of	O
M.	O
bovis	I:C0085957
BCG	I:C0085957
and	O
M.	O
tuberculosis	I:C0026926
.	O

We	O
used	O
enzymological	O
and	O
structural	O
studies	I:C2603343
to	O
investigate	B:C0220825
derivatives	O
of	O
the	O
inhibitors	O
identified	O
and	O
to	O
test	O
their	O
effects	O
on	O
growth	O
of	O
M.	O
bovis	I:C0085957
BCG	I:C0085957
and	O
M.	O
tuberculosis	I:C0026926
.	O

We	O
used	O
enzymological	O
and	O
structural	O
studies	I:C2603343
to	O
investigate	O
derivatives	O
of	O
the	O
inhibitors	B:C0243077
identified	O
and	O
to	O
test	O
their	O
effects	O
on	O
growth	O
of	O
M.	O
bovis	I:C0085957
BCG	I:C0085957
and	O
M.	O
tuberculosis	I:C0026926
.	O

We	O
used	O
enzymological	O
and	O
structural	O
studies	I:C2603343
to	O
investigate	O
derivatives	O
of	O
the	O
inhibitors	O
identified	O
and	O
to	O
test	O
their	O
effects	O
on	O
growth	O
of	O
M.	B:C0085957
bovis	I:C0085957
BCG	I:C0085957
and	O
M.	O
tuberculosis	I:C0026926
.	O

We	O
used	O
enzymological	O
and	O
structural	O
studies	I:C2603343
to	O
investigate	O
derivatives	O
of	O
the	O
inhibitors	O
identified	O
and	O
to	O
test	O
their	O
effects	O
on	O
growth	O
of	O
M.	O
bovis	I:C0085957
BCG	I:C0085957
and	O
M.	B:C0026926
tuberculosis	I:C0026926
.	O

The	O
hsaD	B:C0017337
deleted	O
strain	O
was	O
unable	O
to	O
grow	O
on	O
cholesterol	O
as	O
sole	O
carbon	O
source	O
but	O
did	O
grow	O
on	O
glucose	O
.	O

The	O
hsaD	O
deleted	B:C1511760
strain	O
was	O
unable	O
to	O
grow	O
on	O
cholesterol	O
as	O
sole	O
carbon	O
source	O
but	O
did	O
grow	O
on	O
glucose	O
.	O

The	O
hsaD	O
deleted	O
strain	O
was	O
unable	B:C1299582
to	O
grow	O
on	O
cholesterol	O
as	O
sole	O
carbon	O
source	O
but	O
did	O
grow	O
on	O
glucose	O
.	O

The	O
hsaD	O
deleted	O
strain	O
was	O
unable	O
to	O
grow	O
on	O
cholesterol	B:C0008377
as	O
sole	O
carbon	O
source	O
but	O
did	O
grow	O
on	O
glucose	O
.	O

The	O
hsaD	O
deleted	O
strain	O
was	O
unable	O
to	O
grow	O
on	O
cholesterol	O
as	O
sole	O
carbon	B:C0007009
source	O
but	O
did	O
grow	O
on	O
glucose	O
.	O

The	O
hsaD	O
deleted	O
strain	O
was	O
unable	O
to	O
grow	O
on	O
cholesterol	O
as	O
sole	O
carbon	O
source	B:C0449416
but	O
did	O
grow	O
on	O
glucose	O
.	O

The	O
hsaD	O
deleted	O
strain	O
was	O
unable	O
to	O
grow	O
on	O
cholesterol	O
as	O
sole	O
carbon	O
source	O
but	O
did	O
grow	O
on	O
glucose	B:C0017725
.	O

Of	O
seven	O
chemically	O
distinct	O
'	O
hits	O
'	O
from	O
the	O
library	B:C1706082
,	O
two	O
chemical	O
classes	I:C1254351
of	O
fragments	O
were	O
found	O
to	O
bind	O
in	O
the	O
vicinity	O
of	O
the	O
active	O
site	O
of	O
HsaD	O
by	O
X	O
-	I:C0206755
ray	I:C0206755
crystallography	I:C0206755
.	O

Of	O
seven	O
chemically	O
distinct	O
'	O
hits	O
'	O
from	O
the	O
library	O
,	O
two	O
chemical	B:C1254351
classes	I:C1254351
of	O
fragments	O
were	O
found	O
to	O
bind	O
in	O
the	O
vicinity	O
of	O
the	O
active	O
site	O
of	O
HsaD	O
by	O
X	O
-	I:C0206755
ray	I:C0206755
crystallography	I:C0206755
.	O

Of	O
seven	O
chemically	O
distinct	O
'	O
hits	O
'	O
from	O
the	O
library	O
,	O
two	O
chemical	O
classes	I:C1254351
of	O
fragments	B:C0486805
were	O
found	O
to	O
bind	O
in	O
the	O
vicinity	O
of	O
the	O
active	O
site	O
of	O
HsaD	O
by	O
X	O
-	I:C0206755
ray	I:C0206755
crystallography	I:C0206755
.	O

Of	O
seven	O
chemically	O
distinct	O
'	O
hits	O
'	O
from	O
the	O
library	O
,	O
two	O
chemical	O
classes	I:C1254351
of	O
fragments	O
were	O
found	O
to	O
bind	O
in	O
the	O
vicinity	O
of	O
the	O
active	O
site	O
of	O
HsaD	B:C2352472
by	O
X	O
-	I:C0206755
ray	I:C0206755
crystallography	I:C0206755
.	O

Of	O
seven	O
chemically	O
distinct	O
'	O
hits	O
'	O
from	O
the	O
library	O
,	O
two	O
chemical	O
classes	I:C1254351
of	O
fragments	O
were	O
found	O
to	O
bind	O
in	O
the	O
vicinity	O
of	O
the	O
active	O
site	O
of	O
HsaD	O
by	O
X	B:C0206755
-	I:C0206755
ray	I:C0206755
crystallography	I:C0206755
.	O

The	O
compounds	B:C1706082
also	O
inhibited	O
growth	O
of	O
M.	O
tuberculosis	I:C0026926
on	O
cholesterol	O
.	O

The	O
compounds	O
also	O
inhibited	O
growth	O
of	O
M.	B:C0026926
tuberculosis	I:C0026926
on	O
cholesterol	O
.	O

The	O
compounds	O
also	O
inhibited	O
growth	O
of	O
M.	O
tuberculosis	I:C0026926
on	O
cholesterol	B:C0008377
.	O

The	O
most	O
potent	O
inhibitor	B:C0243077
of	O
HsaD	O
was	O
also	O
found	O
to	O
be	O
the	O
best	O
inhibitor	O
of	O
mycobacterial	O
growth	O
on	O
cholesterol	O
-	O
supplemented	O
minimal	O
medium	O
.	O

The	O
most	O
potent	O
inhibitor	O
of	O
HsaD	B:C2352472
was	O
also	O
found	O
to	O
be	O
the	O
best	O
inhibitor	O
of	O
mycobacterial	O
growth	O
on	O
cholesterol	O
-	O
supplemented	O
minimal	O
medium	O
.	O

The	O
most	O
potent	O
inhibitor	O
of	O
HsaD	O
was	O
also	O
found	O
to	O
be	O
the	O
best	O
inhibitor	O
of	O
mycobacterial	O
growth	O
on	O
cholesterol	B:C0008377
-	O
supplemented	O
minimal	O
medium	O
.	O

We	O
propose	O
that	O
HsaD	B:C2352472
is	O
a	O
novel	O
therapeutic	O
target	O
,	O
which	O
should	O
be	O
fully	O
exploited	O
in	O
order	O
to	O
design	O
and	O
discover	O
new	O
anti-tubercular	O
drugs	I:C0003448
.	O

We	O
propose	O
that	O
HsaD	O
is	O
a	O
novel	O
therapeutic	O
target	O
,	O
which	O
should	O
be	O
fully	O
exploited	O
in	O
order	O
to	O
design	O
and	O
discover	O
new	O
anti-tubercular	B:C0003448
drugs	I:C0003448
.	O

